Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Pablo PandolfoRodrigo A Cunha

Abstract

Attention deficit hyperactivity disorder (ADHD) likely involves dopaminergic dysfunction in the frontal cortex and striatum, resulting in cognitive and motor abnormalities. Since both adenosine and dopamine modulation systems are tightly intertwined, we tested if caffeine (a non-selective adenosine receptor antagonist) attenuated the behavioral and neurochemical changes in adolescent spontaneously hypertensive rats (SHR, a validated ADHD animal model) compared to their control strain (Wistar Kyoto rats, WKY). SHR were hyperactive and had poorer performance in the attentional set-shifting and Y-maze paradigms and also displayed increased dopamine transporter (DAT) density and increased dopamine uptake in frontocortical and striatal terminals compared with WKY rats. Chronic caffeine treatment was devoid of effects in WKY rats while it improved memory and attention deficits and also normalized dopaminergic function in SHR. Additionally, we provide the first direct demonstration for the presence of adenosine A2A receptors (A2AR) in frontocortical nerve terminals, whose density was increased in SHR. These findings underscore the potential for caffeine treatment to normalize frontocortical dopaminergic function and to abrogate attent...Continue Reading

References

Nov 21, 1995·Brain Research. Developmental Brain Research·M H TeicherJ C Hostetter
May 3, 2000·Medical Hypotheses·D R Lara, D O Souza
Feb 24, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·B VitielloD P Cantwell
Mar 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Attila KöfalviBeáta Sperlágh
Jun 14, 2005·Biological Psychiatry·Terje SagvoldenMehdi Farshbaf
Jun 14, 2005·Biological Psychiatry·Bertha K MadrasAlan J Fischman
Mar 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stan B FlorescoOrsolya Magyar
Jul 25, 2007·Progress in Neurobiology·S N SchiffmannS Ferré
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Reinaldo Naoto TakahashiRui Daniel Schroder Prediger
Dec 20, 2007·Journal of Neurochemistry·Sergi Ferré
Jun 10, 2008·Current Pharmaceutical Design·Rodrigo A CunhaJiang-Fan Chen
Jun 27, 2009·Annual Review of Neuroscience·T W Robbins, A F T Arnsten
Dec 15, 2010·Biochimica Et Biophysica Acta·Catarina V GomesRodrigo A Cunha
Jan 18, 2011·Pharmacology, Biochemistry, and Behavior·Rafael Roesler, Nadja Schröder
Jan 27, 2011·European Journal of Pharmacology·Pablo PandolfoAttila Köfalvi
May 28, 2011·The European Journal of Neuroscience·Ana R CostenlaAlexandre de Mendonça
Sep 29, 2011·Archives of Internal Medicine·Michel LucasAlberto Ascherio

❮ Previous
Next ❯

Citations

Sep 24, 2013·Neurochemistry International·Lisiane O PorciúnculaDenis B Rosemberg
Jul 5, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sucharita S SomkuwarLinda P Dwoskin
Apr 15, 2014·Brain Research Bulletin·Jana D TchekalarovaPavel Mareš
Apr 15, 2014·Neuroscience·A P ArdaisL O Porciúncula
Jan 23, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Douglas Teixeira LeffaIraci L S Torres
May 23, 2015·Biomolecules & Therapeutics·Darine Froy N MabungaSe Young Choung
May 6, 2015·British Journal of Pharmacology·N PagnussatL O Porciúncula
May 29, 2016·Physiology & Behavior·Fernanda HansenCarlos-Alberto Gonçalves
May 26, 2016·Journal of Neurochemistry·Rafael BritoKarin C Calaza
Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
Jan 25, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Angelo Fabio GiganteGiuseppe Rubini
Sep 28, 2017·Molecular Psychiatry·A ChefferH Ulrich
Oct 2, 2013·Journal of Motor Behavior·Andrea M EstevesMarco Tulio de Mello
Jul 28, 2017·Expert Review of Neurotherapeutics·Jennifer DownsDavid W Dunn
Oct 22, 2015·Attention Deficit and Hyperactivity Disorders·Katie Grogan, Jessica Bramham
Jan 9, 2019·Frontiers in Molecular Neuroscience·Douglas T LeffaSamira G Ferreira
Nov 22, 2014·Biomolecules & Therapeutics·Chang Soon ChoiGeon Ho Bahn
Apr 30, 2019·Frontiers in Cellular Neuroscience·Jianhong ZhouJiang-Fan Chen
Oct 24, 2020·Neurochemical Research·Lílian Juliana LissnerCarlos-Alberto Gonçalves
Dec 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Joana I GomesSandra H Vaz
Oct 31, 2020·Frontiers in Neuroscience·Simona CovielloJuan Nacher
Feb 20, 2021·Pharmacology & Therapeutics·Aleksandra SzopaPiotr Wlaź
Nov 11, 2019·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniele Guilhermano MachadoLisiane O Porciúncula

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.